Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adriamycin in ovarian cancer patients resistant to cyclophosphamide.

× No keyword cloud information.

6 in total

Review 1. Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors: Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal: J Pharmacol Exp Ther Date: 2019-02-08 Impact factor: 4.030

Review 2. Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors: R M Canetta; S K Carter
Journal: J Cancer Res Clin Oncol Date: 1984 Impact factor: 4.553

3. Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.

Authors: M D Green; J L Speyer; J C Wernz; N Colombo; U Beller; F M Muggia; E M Beckman
Journal: Invest New Drugs Date: 1990-08 Impact factor: 3.850

4. In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.

Authors: M J Xu; D S Alberts; R Liu; A Leibovitz; Y Liu
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

5. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Authors: D S Alberts; H S Chen; S E Salmon; E A Surwit; L Young; T E Moon; F L Meyskens
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

6. The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?

Authors: David E Cohn; William S Shimp
Journal: Gynecol Oncol Rep Date: 2015-06-25

6 in total